HeartFlow promoted John Farquhar to CEO starting 1 March.
Farquhar joined HeartFlow in August as COO and became president and a member of the company’s board of directors in January.
John Farquhar, who served as HeartFlow’s COO since August 2021, will now lead the cardiac imaging company as CEO. The move comes just weeks after HeartFlow terminated plans to go public through a merger with a special purpose acquisition company.
HeartFlow promoted John Farquhar to CEO starting 1 March.
Farquhar joined HeartFlow in August as COO and became president and a member of the company’s board of directors in January.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.